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Abstract
People who begin daily smoking at an early age are at greater risk of long-term nicotine addiction. We tested the hypothesis
that associations between nicotinic acetylcholine receptor (nAChR) genetic variants and nicotine dependence assessed in
adulthood will be stronger among smokers who began daily nicotine exposure during adolescence. We compared nicotine
addiction—measured by the Fagerstrom Test of Nicotine Dependence—in three cohorts of long-term smokers recruited in
Utah, Wisconsin, and by the NHLBI Lung Health Study, using a candidate-gene approach with the neuronal nAChR subunit
genes. This SNP panel included common coding variants and haplotypes detected in eight a and three b nAChR subunit
genes found in European American populations. In the 2,827 long-term smokers examined, common susceptibility and
protective haplotypes at the CHRNA5-A3-B4 locus were associated with nicotine dependence severity (p=2.0610
25; odds
ratio=1.82; 95% confidence interval 1.39–2.39) in subjects who began daily smoking at or before the age of 16, an exposure
period that results in a more severe form of adult nicotine dependence. A substantial shift in susceptibility versus protective
diplotype frequency (AA versus BC=17%, AA versus CC=27%) was observed in the group that began smoking by age 16.
This genetic effect was not observed in subjects who began daily nicotine use after the age of 16. These results establish a
strong mechanistic link among early nicotine exposure, common CHRNA5-A3-B4 haplotypes, and adult nicotine addiction in
three independent populations of European origins. The identification of an age-dependent susceptibility haplotype
reinforces the importance of preventing early exposure to tobacco through public health policies.
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Introduction
Nicotine addiction has profound clinical and public health
consequences because it is associated with reduced ability to cease
tobacco use [1,2], and tobacco use is the leading cause of
preventable morbidity and mortality in developed countries [3].
Meta-analysis of numerous twin studies shows that both genes and
environment play an important role in smoking-related behaviors
[4]. Nicotine is the primary agent in tobacco smoke that leads to
addiction, and while progress has been made in finding genes that
contribute to nicotine addiction in humans [5–9], there is a great
need for additional progress.
Both human and animal research support an a priori hypothesis
that age of onset of daily smoking may influence the association of
genetic risk variants with measures of nicotine dependence. In
humans, early onset of smoking is associated with greater
consumption of cigarettes in adulthood [10–15], a relative inability
to quit smoking [10,16–18], and a more severe form of nicotine
dependence [13,19–22]. Research in rodents shows that nicotine
exposure during periadolescence induces long-lasting biochemical,
anatomical, physiological, and behavioral changes that differ
markedly from those seen with adult exposure [23–27].
The neuronal nicotinic acetylcholine receptor genes (nAChRs)
are likely candidates for harboring functional variants contributing
to nicotine addiction since these ligand-gated ion channels are the
initial physiological targets of nicotine in the central and
peripheral nervous system. They have also been implicated in
nicotine addiction in animals where chronic nicotine exposure
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engineered mouse models support the crucial role of the a4b2
nAChRs in nicotine addiction [30,31]. Previous candidate gene
association studies using six CHRNA4 SNPs found evidence for
associations with measures of nicotine dependence in Chinese men
[5], and females of European-American and African-American
descent [6]. A wider survey of nAChR gene variants in a case-
control study for nicotine dependence found evidence for
nominally significant associations in CHRNA7, CHRNA9, CHRNA5
and CHRNB3 in young Israeli women [7]. Several recent genome-
wide association studies (GWAS) using either nicotine dependent
smokers as cases and non-dependent smokers as controls [8] or
cigarettes per day as a quantitative trait [32] have failed to yield
statistically significant findings at the genome-wide level. However,
when these studies independently examined nAChR candidate
genes [9,32], evidence was found for associations between
common variants in CHRNB3 and the CHRNA5-A3-B4 gene
cluster at 15q 24 and their respective phenotypes. Most recently,
and subsequent to submission of this article, three separate GWAS
reports provide strong evidence for an association between SNP
variation at 15q24 and lung cancer [33–35]. One study suggests
that the effect of 15q24 variants on lung cancer is primarily
mediated through smoking behavior [35], while the other studies
failed to associate 15q24 variants with smoking behavior and
suggest that the disease mechanism with lung cancer is not
explained by an association with nicotine addiction [33,34].
This report describes results of a comprehensive haplotype
discovery and nicotine addiction association study within nAChRs
genes across three European American populations of 2,827 long-
term smokers. Moreover, it tests the a priori hypothesis that
associations between nAChR genetic variants and nicotine
dependence severity assessed in adulthood will be stronger among
smokers who began daily smoking in adolescence than among
those who did not. The results show significant dependence-
haplotype associations in the CHRNA5-A3-B4 gene cluster
occurring only in the early onset subjects, consistent with the
hypothesis that the association of genetic risk variants for nicotine
addiction may be influenced by the age of onset of daily smoking.
Results
Study Populations
Nicotine dependence was assessed with the Fagerstrom Test of
Nicotine Dependence (FTND) because it predicts important
dependence attributes such as the likelihood of relapse back to
tobacco use and biochemical measures of nicotine self-administra-
tion [2,36,37]. The FTND assesses a pattern of heavy, compulsive
smoking andhas beenused inothergeneticassociationstudies[5–9].
Genetic variants were assessed in 2,827 subjects from three
European American cohorts with a mean age of 49.6 years
(SD=9.5), 1155 (41%) of whom were females (Table S1). All
participants were either current or previous daily cigarette smokers;
222 (8%) had not smoked for at least 2 years prior to participation in
the study. One cohort comprised participants in a study of genetic
risk factors for nicotine dependence and chronic obstructive
pulmonary disease (COPD) recruited in Salt Lake City, Utah
(N=486, UT). Another cohort was made up of participants in
randomized trials of smoking cessation interventions recruited in
Madison and Milwaukee, Wisconsin (N=398, WI). A final cohort
was drawn from the Lung Health Study (N=1943, LHS), a multi-
site longitudinal study of COPD sponsored by the Division of Lung
Disease of the National Heart,Lung and Blood Institute [38]. All ex-
smokers were in the UT cohort and responded to smoking related
assessments based upon their prior smoking patterns [39].
Participants began daily smoking at a mean age of 17.3 (SD=4.1),
smoked a mean of 28.3 cigarettes per day (CPD, SD=13.9), smoked
foramean30.7years(SD=9.5),andhadameanFTNDscoreof5.7
(SD=2.2).Consistent withahistoryofchronic,heavysmoking,most
subjects in the UT and LHS cohorts (N=2302, 81% of the total
sample)had mildtomoderatechronicobstructivepulmonarydisease
(COPD) as determined by pulmonary function testing; lung function
testing was not performed on the WI subjects.
Age of onset of daily smoking was dichotomized into early onset
(onset of daily smoking at age 16 or younger) vs. late onset (onset of
daily smoking at age 17 or older). Previous studies have shown that
16 vs. 17 is an appropriate age range to differentiate the impact of
early from late nicotine exposure on dependence [40]. We used a
dichotomous variable to represent age because the effect was
hypothesized to be nonlinear in nature due to the fact that nicotine
exerts distinct effects when administered during adolescence vs.
adulthood [24]. We attempted to reflect this underlying causal
model in our analyses by creating an age cut-score that reflected
this nonlinear effect. Also, the age 16 vs. 17 dichotomy
approximated a median split, which yielded near equivalent
statistical power for tests within the two age samples; 46% of the
sample were thus classified as early onset smokers. Research
suggests that age of smoking onset can be reliably assessed with
retrospective assessments [41]. To compare distinct levels of
nicotine dependence, FTND scores were dichotomized into low
(FTND=0–4) and high (FTND=6–10) dependence [7]. An
FTND score of 6 or higher identifies subjects with high nicotine
dependence [42], while a score of ‘‘5’’ has an ambiguous relation
with dependence [42–44]. Of the initial sample of 2827, 731 (26%)
were assigned to the low dependence condition, 1556 (55%) were
assigned to the high dependence condition and 540 (19%) had an
intermediate score of 5.
Consistent with previous reports, age of onset of daily smoking
was inversely related to level of dependence in the present sample.
Age of onset and FTND score were correlated, r(2135)=20.18,
P,0.001, and dichotomized age of onset and FTND were highly
associated (x2=51.6, 1 df, P,0.001). In early onset smokers,
24.2% had low FTND scores compared with 38.7% of late onset
smokers.
Author Summary
Tobacco use is a global health care problem, and
persistent smoking takes an enormous toll on individual
health. The onset of daily smoking in adolescence is
related to chronic use and severe nicotine dependence in
adulthood. Since nicotine is the key addictive chemical in
tobacco, we tested the hypothesis that genetic variants
within nicotinic acetylcholine receptors will influence the
severity of addiction measured in adulthood. Using
genomic resequencing to define the patterns of variation
found in these candidate genes, we observed that
common haplotypes in the CHRNA5-A3-B4 gene cluster
are associated with adult nicotine addiction, specifically
among those who began daily smoking before age 17. We
show that in populations of European origins, one
haplotype is a risk factor for dependence, one is protective,
and one is neutral. These observations suggest that
genetic determinants expressed during human adoles-
cence contribute to the risk of lifetime addiction severity
produced from early onset of cigarette use. Because
disease risk from the adverse health effects of tobacco
smoke is related to lifetime tobacco exposure, the finding
that an age-dependent effect of these haplotypes has a
strong influence on lifetime smoking behavior reinforces
the public health significance of delaying smoking onset.
CHRNA5-A3-B4 and Age-Dependent Addiction
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As an initial step, we conducted an exhaustive SNP discovery
survey surrounding the neuronal nAChR coding regions in a small
sample selected to represent the most extreme heavy and light
dependent smokers. We used a genomic resequencing strategy to
generate a dense set of variants in a-like nAChR subunits (a2, a3,
a4, a5, a6, a9, and a10) and b-like nAChR subunits (b2, b3, and
b4) in 144 smokers and 48 population-matched non-smokers. This
survey identified 262 SNPs, including 38 nonsynonymous, 35
synonymous, 57 UTR, 1 stop, and 1 frameshift (see Table S2 for
location and allele frequency). The stop and frameshift alleles,
both located in CHRNA6, were each observed as heterozygotes in
single individuals, indicating that the depth of the resequencing
survey reached the boundary of rare loss-of-function alleles. For a
preliminary x2 analysis of association in the resequencing sample,
we subdivided the 144 smokers into high (n=72) and low-
dependent (n=72) categories. Even with this small selected sample
set, a nominally significant association signal (P,0.01) was observed
for five SNPs located intheCHRNA5-A3-B4cluster on chromosome
15q25: rs951266 (intronic A5), rs16969968 (nonsynonymous A5),
rs8192482 (39-UTR A5), rs4887067 (intergenic A5-A3) and
rs17487223 (intronic B4). All five SNPs are in strong linkage
disequilibrium. In order to extend this survey, we defined haplotype
structures in all nAChR subunits based on inference from the
unphased resequencing data, and derived a minimal set of tagging
SNPs (n=87) for genotyping in the larger three-cohort sample.
Genotyping of all 87 tagging SNPS across the neuronal nAChR
a and b subunits was first carried out in the UT (n=439) and WI
cohorts (n=339), and single marker allelic tests using x
2 statistics
were evaluated for association with FTND scores in early versus
late onset samples (Table S3). The strongest association signals
(P,0.005) to dichotomized FTND by age of onset were observed
only in the early onset sample for six SNPs within the CHRNA5-
A3-B4 gene cluster with significant allele test P values ranging from
4.8610
23 to 5.0610
24 (Table 1). No other nAChR SNP had a P
value less than 0.02 in either the early or late onset group. These six
CHRNA5-A3-B4 SNPs stratified into two groups of significant linkage
disequilibrium (LD), and examination of phased resequencing
haplotypes (Figure 1) revealed that these association signals occur
within a ,50 kb LD block-like structure spanning CHRNA5 and
CHRNA3. This LD block in the resequencing samples is composed of
four major haplotypes: Haplotype A (HA)=38%, Haplotype B
(HB)=34%, Haplotype C (HC)=20%,HaplotypeD(H D)=5%.
CHRNA5-A3-B4 Haplotype Effects
To evaluate the significance of these CHRNA5-CHRNA3 single
marker associations and the underlying haplotypes, five tagging
SNPs capable of distinguishing these four haplotypes were assessed
for association to FTND by age of daily smoking onset (daily
smoking onset by vs. after age 16) in the combined UT-WI-LHS
cohorts (total N=2,827). Observed frequencies of Haplotypes A–
D, respectively, by cohort were as follows: LHS, 39%, 37%, 19%,
and 5%; UT, 38%, 38%, 20%, and 4%; and WI, 41%, 38%, 17%,
and 4%. A test of all four haplotypes showed a significant omnibus
association P value of 2.6610
24 with high vs. low FTND score
within the early onset group (Table 2), but not within the late onset
group (P=0.444). This omnibus haplotype test was supported by
single marker association P values ranging from 1.1610
23 to
1.7610
24 (Figure 1). The main haplotype effect can be partitioned
into two significant haplotype-specific associations (Table 2) with
both a susceptibility effect for high dependence in the early onset
group for haplotype HA (odds ratio (OR) 1.50, 95% CI 1.21 to
1.86, P=1.3610
24), and a protective effect for haplotype HC (OR
0.66, 95% CI 0.52 to 0.85, P=1.1610
23). Importantly, haplotype
HB shows no significant association (OR 0.93, 95% CI 0.76 to
1.14, P=0.50), suggesting that the two haplotype-specific
associations are the result of distinct susceptibility (HA) and
protective (HC) haplotype effects in the early onset group.
An interaction between haplotype status and age of onset in
predicting dependence severity was also obtained via logistic
Table 1. Association of CHRNA5 – A3 – B4 SNPs with Dichotomized FTND Scores in the UT and WI Cohorts.
SNP Gene Location
Chr. 15
Position
a
Minor
allele Early onset of daily smoking by 16 Late onset of daily smoking after 16
Frequency:
Low, High
b p-Value
Allelic OR
(95% CI)
Frequency:
Low, High
c p-Value
Allelic OR
(95% CI)
rs17486278 CHRNA5 intron 1 76654537 C 0.279, 0.417 0.0005 1.85 (1.31–2.62) 0.403, 0.395 0.81 0.96 (0.72–1.29)
rs680244 CHRNA5 intron 1 76658343 A 0.461, 0.419 0.32 0.84 (0.61–1.17) 0.406, 0.401 0.88 0.98 (0.73–1.31)
rs569207 CHRNA5 intron 1 76660174 A 0.260, 0.167 0.0042 0.57 (0.39–0.84) 0.191, 0.203 0.68 1.08 (0.75–1.54)
rs555018 CHRNA5 intron 3 76666297 C 0.462, 0.415 0.25 0.83 (0.60–1.15) 0.407, 0.400 0.85 0.97 (0.73–1.30)
rs16969968 CHRNA5 Asn348Asp 76669980 A 0.284, 0.415 0.0009 1.79 (1.27–2.54) 0.401, 0.400 0.97 1.00 (0.75–1.33)
rs578776 CHRNA3 39 UTR 76675455 T 0.317, 0.218 0.0048 0.60 (0.42–0.86) 0.218, 0.223 0.87 1.03 (0.73–1.45)
rs1051730 CHRNA3 Gly394Gly 76681394 T 0.284, 0.415 0.0009 1.79 (1.27–2.54) 0.398, 0.401 0.93 1.01 (0.76–1.35)
rs2869546 CHRNA3 intron 4 76694400 C 0.394, 0.374 0.61 0.92 (0.66–1.28) 0.384, 0.374 0.77 0.96 (0.72–1.28)
rs7177514 CHRNA3 intron 4 76694461 G 0.341, 0.235 0.0032 0.59 (0.42–0.84) 0.229, 0.245 0.59 1.10 (0.78–1.53)
rs12443170 CHRNA3 intron 4 76694791 A 0.149, 0.096 0.038 0.61 (0.38–0.98) 0.111, 0.148 0.13 1.39 (0.91–2.13)
rs11636605 CHRNB4 intron 1 76715933 A 0.212, 0.156 0.072 0.69 (0.46–1.04) 0.159, 0.182 0.40 1.18 (0.80–1.72)
rs11633223 CHRNB4 59 flank 76722531 C 0.414, 0.378 0.37 0.86 (0.62–1.20) 0.384, 0.376 0.81 0.96 (0.72–1.29)
rs3971872 CHRNB4 59 flank 76729090 T 0.096, 0.092 0.86 0.95 (0.55–1.65) 0.068, 0.079 0.57 1.17 (0.68–2.02)
Data in bold indicate significant SNPs.
aChromosome 15 coordinates from NCBI Build 36.1 (hg18).
bMinor allele frequency in Low (FTND=0–4, n=106) and High (FTND=6–10, n=271).
cMinor allele frequency in Low (FTND=0–4, n=183) and High (FTND=6–10, n=217).
doi:10.1371/journal.pgen.1000125.t001
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(P=0.006) was found, as well as a significant HA vs. HC contrast
within the early onset condition (P=2.0610
25, OR=1.82, 95%
CI 1.39 to 2.39). HC was associated with reduced likelihood of
severe nicotine dependence relative to HA, but only among those
smoking daily at age 16 or younger. Gender was associated with
age of onset in our cohorts (41% of females began daily smoking
before age 17 compared with 49% of males). However, gender did
not moderate the relation between dependence and haplotype
status within age of onset groups and so was dropped from
subsequent analyses. Based on these results for the entire sample,
haplotype associations with the dichotomized FTND variable were
tested by age of onset condition within each cohort separately
(Table 4). There was a significant HA vs. HC contrast in the early
onset group for each cohort (P’s=0.0220.001, OR’s=1.5–3.0),
but this contrast was not significant in any cohort in the late onset
condition. Thus, the relative risk/protective effect of haplotypes A
and C was found only in early onset smokers in three separate
cohorts.
Diplotype analyses also suggest that age-of-onset moderates the
relation of these variants with nicotine dependence (Figure 2).
Logistic regression analysis in the combined sample showed a
significant interaction between the diplotype status (AA vs. BC)
and age-of-onset (P=0.02, OR=0.43, 95% CI 0.86 to 0.21).
Analyses in the early onset group found significant differences
between diplotype AA and all other tested diplotypes (P value
Figure 1. Haplotype Structure and Association Results in the Nicotinic a5, a3 and b4 Receptor Subunit Genes on Chromosome
15q24. (A) Genomic region of CHRNA5-A3-B4 transcription units on chr. 15 between 76,644,000 to 76,732,000 base pairs (NCBI Build 36). 2log10(P
value) plot of SNPs as a function of genomic position, with their P values (allele association values from chi square tests) observed in the early onset
condition. The symbols indicate haplotype assignment (HA,H B,H C and HD) of the individual markers; open symbols indicate P values in the UT-WI
cohorts and shaded symbols indicate P values in the combined UT-WI-LHS cohorts. The five SNPs used to assign haplotype status in the UT-WI-LHS
cohorts are colored by haplotype affiliation: red (HA), (blue (HC) or beige (HB). (B) fastPHASE inferred haplotype structure of the region from unphased
resequencing and genotypic data from 384 chromosomes (resequencing sample cohort). Haplotypes were assigned to groups using the 5 SNPs
genotyped in the UT-WI-LHS cohorts (rs680244, rs569207, rs16969968, rs578776, and rs1051730). Haplotype counts for HA,H B,H C, HD and not
assigned (na) are shown on the left, and the positions of SNPs genotyped in the UT-WI cohorts are indicated above the haplotypes by blue and in the
UT-WI-LHS cohorts by green indicators.
doi:10.1371/journal.pgen.1000125.g001
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24). The contrast between diplotype AA
vs. diplotype AC (P=0.03, OR=0.53, 95% CI 0.93 to 0.30) and
diplotype AA vs. diplotype BC (P=3.0610
24, OR=0.35, 95% CI
0.62 to 0.20) suggests a recessive effect of Haplotype A, and an
incomplete dominance effect of Haplotype C (Figure 2A).
To ensure that the obtained results were not dependent upon
the particular age of daily smoking onset or FTND dichotomy that
was used, the effects for both phenotypes were investigated in
more detail. First, the interaction between haplotype and age of
onset as a continuous variable was tested based on the combined
UT-WI-LHS cohorts and using FTND46 as the dependent
variable. The HA vs. HC by daily age interaction effect was
significant, p=0.01, OR=0.95 (95% CI=0.91–0.99), but the HB
vs. HC interaction effect was not significant, p=0.24, OR=0.98
(95% CI=0.94–1.02). Next, subjects where divided into quartiles
based on onset age of daily smoking and the haplotype effects
within each quartile were tested separately. Table 5 shows the
logistic regression analysis for the HA vs. HC effect was significant
in the two younger quartiles (p=0.0003 for 15–16 years and
p=0.01 for ,15 years), but not in the two older quartiles (p=0.43
for 17–18 years and p=0.63 for .18 years). Figure 3 shows the
relative haplotype frequencies across each age group quartile.
Prior research suggested that the FTND score of ‘‘5’’ constitutes
an intermediate score that is ambiguous with regards to
dependence level [42–44]. To explore this assumption we
conducted a multinomial logistic regression with all subjects in
which haplotype status was related to an FTND dependent
variable that was split into three levels: ‘‘Low’’ (i.e., scores 0–4,
Table 2. CHRNA5-A3-B4 Haplotype-Specific Association with Dichotomized FTND Scores in the UT-WI-LHS Cohorts.
Haplotype
Haplotype
Tags
a Early onset of daily smoking by 16 Late onset of daily smoking after 16
Frequency
FTND=0–4
Frequency
FTND=6–10 pHS ORHS (95% CI)
Frequency
FTND=0–4
Frequency
FTND=6–10 pHS ORHS (95% CI)
(n=256) (n=795) (n=493) (n=776)
HA CCAGA 0.318 0.413 0.00013 1.50 (1.21–1.86) 0.381 0.412 0.12 1.14 (0.97–1.34)
HB TCGGG 0.375 0.358 0.50 0.93 (0.76–1.14) 0.385 0.365 0.30 0.91 (0.77–1.08)
HC CTGAG 0.244 0.179 0.00107 0.66 (0.52–0.85) 0.192 0.187 0.74 0.96 (0.78–1.19)
HD TCGAG 0.063 0.051 0.33 0.81 (0.53–1.23) 0.042 0.035 0.47 0.86 (0.57–1.29)
aThe haplotype-tagging SNPs are rs680244, rs569207, rs16969968, rs578776, rs1051730, and the tag sequences are from the chr. 15 (+) strand.
Data in bold indicate significant haplotype-specific tests (phs); an omnibus haplotype test was significant in the early onset group (p=0.00026) but not in the late onset
group (p=0.444).
doi:10.1371/journal.pgen.1000125.t002
Table 3. Logistic Regression Analyses in which Low and High Nicotine Dependence (FTND=0–4 vs. FTND=6–10) Was the
Dependent Variable and Haplotype C Was the Reference Condition.
Haplotype Interaction
a Early onset of daily smoking by 16 Late onset of daily smoking after 16
N P OR (95% CI) N p OR (95% CI) N p OR (95% CI)
HA 2210 0.006 1.65 (1.16–2.35) 988 2.0610
25 1.82 (1.39–2.39) 1222 0.38 1.11 (0.88–1.39)
HB 2094 0.08 1.36 (0.96–1.94) 935 0.04 1.33 (1.02–1.74) 1159 0.83 0.98 (0.78–1.22)
aInteraction=interaction between haplotype and early vs. late onset of daily smoking.
N=haplotype count and OR=odds ratio (95% confidence intervals in parentheses). Haplotype C counts by test are: Interaction, 1089; Early Onset, 511; and Late Onset,
578.
doi:10.1371/journal.pgen.1000125.t003
Table 4. Logistic Regression Analyses by Cohort in which Low and High Nicotine Dependence (FTND=0–4 vs. FTND=6–10) Was
the Dependent Variable and Haplotype C Was the Reference Condition.
Cohort Haplotype Early onset of daily smoking by 16 Late onset of daily smoking after 16
p OR (95% CI) p OR (95% CI)
LHS HA 0.02 1.52 (1.07–2.14) 0.19 1.20 (0.91–1.58)
HB 0.21 1.25 (0.88–1.76) 0.87 0.98 (0.74–1.29)
UT HA 0.001 2.97 (1.53–5.76) 0.72 0.91 (0.56–1.48)
HB 0.27 1.42 (0.76–2.66) 0.88 0.96 (0.59–1.57)
WI HA 0.02 2.16 (1.16–4.00) 0.98 1.01 (0.49–2.08)
HB 0.13 1.58 (0.88–2.85) 0.94 1.03 (0.49–2.15)
doi:10.1371/journal.pgen.1000125.t004
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(score.5, 1556). This analysis showed significant haplotype effects
only when individuals with Low vs. High FTND scores were
contrasted with one another. That is, comparisons involving
individuals with Intermediate scores, yielded no significant main
effects or interaction effects. An inspection of haplotype distribu-
tions showed that individuals with mid-range levels of dependence
(FTND of ‘‘5’’) had haplotype distributions that were intermediate
to those of subjects with Low and High scores. Therefore, as would
be expected if haplotypes confer dependence vulnerability, when
dependence levels became more extreme, so were the relative
distributions of haplotypes.
However, we also report secondary analyses with individuals
with the full range of FTND scores, and with different score cut-
points (i.e., FTND scores 0–4 vs. 5–10 and 0–5 vs. 6–10), in order
to demonstrate that the reported pattern of results does not depend
upon exclusion of mid-range scores. With both divisions (FTND
scores 0–4 vs. 5–10 and 0–5 vs. 6–10), the Haplotype A vs. C
interaction with age of onset was significant, as was the Haplotype
A vs. C contrast within early onset but not late onset smokers
(Table S4). Further, diplotype analyses indicated a significant AA
vs. BC interaction with age of onset for both of the additional
FTND divisions and a significant AA vs. BC contrast within the
early but not the late onset condition. Inspection of the relation
between FTND deciles and the frequency of HA relative to HC in
early onset smokers indicated nonlinearity, supporting the choice
to relate genetic variants to dichotomous rather than continuous
FTND scores. Finally, AA vs. BC diplotypes differed significantly
for mean FTND scores in early (P=5 610
24), but not late, onset
smokers (Figure 2C and D).
The psychometric performance of the six-item FTND to assess
physical dependence on tobacco smoking is well established,
particularly items 1 and 4 which relate to heaviness of smoking
[36,37]. The significance levels of analyses of the association
Figure 2. Low Nicotine Dependence (%) and Mean FTND Scores by Diplotype and Age of Onset of Daily Smoking in the Combined
UT-WI-LHS Cohorts. (A), (B) partitioning of diplotypes between FTND,5 and FTND.5 categories in early and late onset groups. The percentage of
individuals in the FTND,5 category is shown by the dichotomous ‘FTND cut’ value (dashed line). (C), (D) mean FTND score of diplotypes by early and
late onset; error bars indicate the S.E.M. Sample size by diplotype within the early onset condition was: AA, 161; AB, 276; AC, 162; BB, 146; BC, 153; and
CC, 34. Within the late onset condition, diplotype sample sizes were: AA, 203; AB, 384; AC, 186; BB, 160; BC, 190; and CC, 34. Diplotype counts are
indicated by the width of each associated column within the plots.
doi:10.1371/journal.pgen.1000125.g002
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Table 6 and positive scores on most items show a trend towards
higher frequency of haplotype HA and a lower frequency of
haplotype HC (Tables S5 and S6). Nominally significant results were
obtained only for FTND item 4 (cigarettes per day) and FTND item
5 (smoking frequently during the first hours after waking). HA vs. HC
associations with FTND items were tested within age of onset
condition using chi-squarefor dichotomous items. For items1 and 4,
which have 4 ordered response options, Cochran’s Test of Linear
Trend was used to test the hypothesis that haplotype proportions
change linearly across the response options. The only nominally
significant results were obtained in the early onset condition for
cigarettes per day (Item 4), Cochran’s Test of Linear Trend (1,
N=1499)=16.6, p,0.00005, and for early morning smoking (Item
5), x2 (1, N=1142)=4.01, p,0.05. In sum, the pattern of findings
suggeststhatmultipleitemscontribute,albeitmodestlyinsomecases,
to the measurement of nicotine dependence as it is associated with
haplotypes. Since the items of the FTND are not highly correlated
with one another, the additive effects of the different items have the
potential to yield orthogonal variance and a more comprehensive
assessment of nicotine dependence than is available via only a subset
of items [2].
Discussion
These results show that CHRNA5-A3-B4 haplotypes are consis-
tently related to severity of nicotine dependence among long-term
smokers of European-American descent who began daily smoking at
or before age 16 but not among those who began smoking daily after
age 16. The robustness of the genotype by age of onset interaction is
supported by the factthat there was a significant interaction between
the two variables in logistic regression analyses and by the fact that
significant associations between genetic variants and dependence
were specific to early onset smokers in all three cohorts. Both human
and animal research shows that early vs. late smoking or nicotine
exposure is associated with more severe nicotine dependence, or
greaternicotineself-administration,manifestedinadulthood[25,45–
47] and that adolescence is a period of heightened sensitivity to
nicotine reward as well as decreased sensitivity to nicotine’s aversive
actions [47–50]. Animal research suggests possible mechanisms for
this effect related to persistent changes in brain structure and
function. For instance, significantly greater high affinity nicotinic
receptor binding is observed in the midbrain and striatum of
adolescent versus adult onset nicotine-self-administering rats [51],
indicating receptor up-regulation. Also, nicotine exerts greater
differential mRNA expression effects on a5, a6a n db2n A C h R
transcripts andon genesthatinfluence neuroplasticity (e.g.,arc)wh en
it is administered to adolescent, as opposed to adult rats [25,52].
The most noteworthy coding SNP contained in the HA LD
structure is rs16969968, a nonsynonymous a5 coding variant
(p.Asp398Asn) resulting in substitution of a negatively charged
residue within the M3–M4 intracellular loop, a region thought to
Figure 3. Low Nicotine Dependence (%) as a Function of
Haplotypes A and C versus Age of Onset of Daily Smoking
Quartiles in the UT-WI-LHS Cohorts. (A) Percentage of each
haplotype in the FTND score,5 category as a function of age of onset
quartiles. The percentage of individuals in the FTND,5 category for
each quartile is shown by the dichotomous ‘FTND cut’ value. The age
range for each quartile, with percentage of total subjects in
parentheses, is as follows: ,15 years (19%), 15–16 years (27%), 17–18
years (26%), and .18 years (29%).
doi:10.1371/journal.pgen.1000125.g003
Table 5. Logistic Regression Analysis for the HA vs. HC Effect
by Age of Daily Smoking Onset Quartile.
Daily Age
a P-value Odds Ratio Upper CI Lower CI
,15 years 0.01 1.76 2.75 1.13
15–16 years 0.0003 1.89 2.68 1.34
17–18 years 0.43 1.15 1.60 0.82
.18 years 0.63 1.08 1.46 0.79
aThe age of daily smoking onset for each quartile, with percentage of total
subjects in parentheses, is as follows: ,15 years (19%), 15–16 years (27%), 17–
18 years (26%), and .18 years (29%).
doi:10.1371/journal.pgen.1000125.t005
Table 6. Associations between Haplotypes and Individual FTND Items.
FTND Item
a p-values
b
Inter All Early Late
1. How soon after you wake up do you smoke your first cigarette? 0.56 0.18 0.19 0.38
2. Do you find it difficult to refrain from smoking in places where it is forbidden? 0.84 0.63 0.68 0.90
3. Which cigarette would you hate most to give up, first one in the morning? 0.93 0.42 0.53 0.58
4. How many cigarettes per day did/do you smoke? 0.18 0.0001 0.0001 0.07
5. Do you smoke more frequently during the first hours after waking than during the rest of the day? 0.28 0.08 0.05 0.58
6. Do you smoke if you are so ill that you are in bed most of the day? 0.25 0.24 0.08 0.83
ap-values for items 1 and 4 are from GLM tests in which the 4 levels of the item responses were taken to be an ordinal variable. For items 2, 3, 5 and 6, p-values are from
logistic regression analyses.
b‘‘Inter’’=the interaction between haplotype and age of onset, ‘‘All’’=all subjects, ‘‘Early’’=early onset smokers only, and ‘‘Late’’=late onset smokers only. For GLM
analyses, the p-value was obtained in a test across HA,H B,a n dH C. For logistic regression analyses, the p-value was for the HA vs. HC effect.
doi:10.1371/journal.pgen.1000125.t006
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surrounding the p.Asp398Asn variant also displays accelerated
protein evolution (higher lineage-specific Ka/Ks) in primate
lineages within a class of genes related to nervous system
development [53]. In mouse brain, a5 is a widely distributed
minor subunit within heteromeric brain nAChRs, and incorpora-
tion of an a5 subunit into brain nAChRs leads to changes in
receptor-level function [54]. The association of HA and the
p.Asp398Asn variant with a nicotine dependence phenotype in
humans suggests further research, such as an engineered mouse
model, to explore the functional role and developmental
expression of these variants within the process leading to chronic
nicotine dependence. Both rs16969968 and rs1051730, a
synonymous a3 variant, are in nearly complete linkage disequi-
librium and, along with the HA LD structure, occur at significantly
higher frequencies in European-American populations based on
HapMap allele frequencies.
In-depth haplotype analysis also revealed a protective effect of
haplotype HC. Multiple non-coding variants are contained within
the HC LD structure; therefore, potential functional variants may
indirectly affect receptor function through developmental and/or
cell-specific expression of a5, a3o rb4 levels. The risk versus
protective effects of HA and HC reinforce an emerging theme in
complex genetics that common and rare alleles can display a range
of protective, neutral and susceptibility effects [55]. The
magnitude of effects reported here (haplotype frequency shifts
,10%, haplotype-specific odds ratios=1.5) fall within the range of
other common variant effects influencing complex diseases, such
as diabetes [56], coronary artery disease [56][57], psoriasis [58]
and inflammatory bowel disease [59]
In our European-American population, we did not find
evidence of significant associations (P,0.05 in early or late onset
smokers) among the four CHRNA4 SNPs in common with our
study (rs2273504, rs2236196, rs1044396, rs1044397; Table S3)
and previous candidate gene association studies of nicotine
dependence in Chinese men [5], and females of European-
American and African-American descent [6]. A follow-up
candidate gene study [9] to a genome-wide association design
[8] with a definition of no dependence (FTND=0) in controls and
a FTND.3 for dependence in cases of European descent,
identified significant associations within CHRNB3 and the
CHRNA5-A3-B4 cluster. Although that study [9] and the current
study employed tagging SNPs for similar LD bins, the current
study did not find any association between nicotine dependence
and CHRNB3 SNPs. However, similar LD bins within the
CHRNA5-A3-B4 cluster showed a significant risk effect in both
studies, including the nonsynonymous a5 rs16969968 SNP, even
with the substantial difference in FTND criteria. Using similar
criteria for low and high dependence as our study, a previous study
[7] also reported a suggestive association (primary P=0.08) of the
CHRNA5-A3-B4 cluster in a small sample population of 242 Israeli
women. A recent follow-up candidate gene analysis using genome-
wide association data from three European populations data
suggested a risk effect of CHRNA5-A3-B4 locus for cigarettes per
day regularly smoked [32].
Subsequent to submission of this article, a GWA study using
smoking quantity (cigarettes per day, CPD) as a measure of
nicotine dependence observed an association of rs1051730 with
CPD at genome-wide significance levels in a large Icelandic
population. That study used FTND item 4 as their measure of
cigarettes per day. Table S7 shows the comparison of our study
and the Icelandic study using cigarettes per day as the one, in
common, phenotype and rs1051730 as the one, in common,
genotype. The trend in the frequency of the rs1051730 T allele is
generally similar, except for the 1–10 cigarettes per day group in
the Icelandic study. Clearly, their population of smokers differs
from the UT-WI-LHS smokers, which is understandable since our
study preferentially enrolled long-term heavy smokers who had
lung disease (UT-LHS) or sought cessation treatment (WI).
Two other GWAS reports using lung cancer case-control
designs, reported that rs1051730 exceeded genome-wide signifi-
cance levels for association with lung cancer but having failed to
measure significant associations with smoking behavior, concluded
that the effect on lung cancer risk was independent of smoking
behavior. Our analysis demonstrating that strong associations
between CHRNA5-A3-B4 variants and nicotine dependence are
seen only amongst smokers who began daily smoking relatively
early in life, coupled with the detailed molecular definition of the
CHRNA5-A3-B4 haplotype structures generated from resequen-
cing, supports the hypothesis that the disease outcome effects of
rs1051730, and other surrogate markers for Haplotype A, are
mediated by nicotine addiction. In our opinion, the biological link
between nicotinic receptor variants and smoking behavior is more
plausible than a direct effect of these ion channels on lung cancer
susceptibility. The association of rs1051730 with lung cancer may
therefore be due to disease mortality related to long-term,
persistent smoking caused by severe nicotine addiction [60,61].
In summary, we have demonstrated that major CHRNA5-A3-B4
haplotypes identify countervailing susceptibility (HA)a n dp r o t e c t i v e
(HC) determinants for long-term nicotine dependence. A substantial
shiftinhaplotypefrequency(Avs.C=10%)anddiplotypefrequency
(AA vs. BC=17%, AA vs. CC=27%) is observed when age of
exposure to nicotine is used to define an at-risk subpopulation.
Identifying this interaction of a common genetic risk factor with age
ofdailysmokingonsetamongthecomplexityoffactorsthatinfluence
nicotine addiction indicates how genetics can augment public health
approaches to the problem of smoking-related illness, because the
riskisamenabletointervention.Identificationofgeneticallyhigh-risk
individuals who would benefit from proactive interventions, such as
adolescenteducationandcessationclinics,mayresultinapopulation
with a lower rate of adult nicotine addiction.
Materials and Methods
Subjects
The UT cohort was made up of respondents to community
advertising for persons who had smoked more than 100 cigarettes
lifetime plus a subset of the originally recruited Utah LHS cohort
who had follow-up phenotyping and biosample collection in Salt
LakeCity,UT;these Utahparticipantswere excludedfromthe LHS
cohort. Participants were not drawn from a psychiatric treatment
population, and no medical or behavioral treatments were offered as
part of the study. UT volunteers were not excluded simply because
they had a lifetime diagnosis of psychosis or Bipolar Disorder, but
they were excluded if their current mental status made it impossible
for them to complete the questionnaires or interviews.
WI participants were recruited by media advertisements and had
to be current smokers who were motivated to quit smoking, smoked
more than 9 CPD, and produced a breath sample with carbon
monoxide (CO) .9 ppm at baseline. Exclusion criteria included
evidence of psychosis history based on the Prime-MD structured
psychiatric interview [62], significant alcohol abuse based on the
Michigan Alcoholism Screening Test [MAST] [63] and clinically
significant depression symptoms based on the CES-D[64]. DNA
extraction for the Wisconsin subjects was performed by the
Wisconsin State Laboratory of Hygiene. Study procedures were
approved by the institutional review boards at the University of
Wisconsin and the University of Utah. All LHS participants had
CHRNA5-A3-B4 and Age-Dependent Addiction
PLoS Genetics | www.plosgenetics.org 8 July 2008 | Volume 4 | Issue 7 | e1000125COPDcompared to62%oftheUTcohort. COPDwas notassessed
inthe WIcohort,but giventheyoungerageofthoseparticipants,itis
likely that relatively few had developed COPD yet. All LHS and WI
participants were smoking at the time they participated in the study,
but 43% of the UT cohort had been tobacco abstinent for the
previous two years. The LHS subjects were restricted to European
Americans for whom DNA was available. De-identified demograph-
ic and phenotypic data was provided from the LHS limited access
dataset by the NIH/NHLBI.
The cohorts differed in age, sex, age of onset of daily smoking,
percent smoking daily by age 16, cigarettes smoked/day (CPD),
and dichotomized Fagerstrom Test of Nicotine Dependence
(FTND) score, but they did not differ in mean FTND (Table
S1). FTND scores of 0–4 were designated low dependence and
scores of 6–10 were designated high dependence. Omitting mid-
range FTND scores eliminated 540 participants (19%) from
further analyses. The number eliminated by cohort was: LHS, 392
(20%); UT, 73 (15%); and WI, 75 (19%). Thus, the final sample
used for FTND association tests comprised 1551 LHS partici-
pants, 413 UT participants, and 323 WI participants (total
N=2287). Some participants (N=692) in the LHS cohort were
missing one FTND item (item 5, a 1-point item), so the N for
FTND score for this cohort is 1251. In the 692 cases missing one
item, those with scores on the remaining 5 items of 0–3 were
assigned to the low dependence group, those with scores of 6–9
were assigned to the high dependence group, and those with scores
of 4 or 5 (N=392) were omitted.
Resequencing of nAChR Genes, SNP Selection, and
Genotyping
DNA samples were obtained from all subjects. The resequencing
sample comprised 144 smokers identified by a multiple predictor
model with unit weighting as being either high or low on a broad
range of dependence measures (e.g., relapse likelihood, withdrawal
severity; N=144) and an additional group of lifetime nonsmokers
(N=48). The University of California Santa Cruz genome browser
was used to extract positions of proximal promoters and RefSeq
exons for CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6,
CHRNA7 (unique 59 only),CHRNA9, CHRNA10, CHRNB2, CHRNB3
and CHRNB4. Exons, genomic sequences conserved in mouse, and
,1k b o f 5 9 and 39 flanking regions were targeted by DNA
sequencing, as previously described [65]. The resequencing scan
surveyed a total range of 56,620 nts. in each of 192 individuals of
Northern European descent; survey coordinates from NCBI Build 35
for genomic ranges surveyed with a Phrap quality score of .30 are:
CHRNA2 [Chr. 8] 27374096::27375538, 27376211::27377643,
27380318::27381167, 27382561::27383658, 27384018::27384835,
27392219::27392738 nts.; CHRNA5-CHRNA3-CHRNB4 [Chr. 15]
76644811::76645440, 76651089::76651811, 76659985::76660542,
76665576::76666420, 76667214::76668294, 76668898::76670309,
76672128::76676199, 76680573::76681761, 76696115::76696969,
76697824::76698624, 76700082::76700676, 76703348::76704858,
76708170::76709554, 76710234::76710990, 76713688::76715398,
76720101::76721040 nts.; CHRNA4 [Chr. 20] 61446755::61447910,
61448032::61448901, 61451297::61452331, 61457596::61458129,
61457956::61458391, 61461159::61461713 nts.; CHRNB3-CHRNA6
[Chr. 8] 42671565::42672135, 42682775::42683415,
42684268::42684976, 42704488::42705250, 42705850::42706962,
42710633::42711239, 42721158::42721408, 42726921::42727704,
42730060::42731305, 42730845::42731665, 42733016::42733750,
42739105::42739734, 42742436::42743042 nts.; CHRNA9 [Chr. 4]
40177941::40178826, 40178370::40179265, 40179840::40180696,
40191528::40192719, 40192719::40198282 nts.; CHRNA10 [Chr.
11] 3643245::3644701, 3644675::3645949, 3647081::3647752,
3647274::3648079, 3648702::3649607 nts.; CHRNB2 [Chr. 1]
151353228::151353745, 151354953::151356224, 151356569::
151357823, 151361153::151362332 nts.
Forward and reverse PCR primer sequences were chosen from
the publiclyavailablegenomicsequence,andPCRamplificationwas
carried out in 25 ml reaction volumes using standard techniques
(primer sequences are available from the authors upon request).
Amplification primers and unincorporated nucleotides were re-
moved using ExoSAP-IT (USB, Cleveland, Ohio). For sequencing,
internal primers were used, and cycle sequencing was carried out
using Applied Biosystems BigDye terminator chemistry. Cycling was
done with an initial denaturation at 96uC for 30 sec.; followed by 45
cycles of 96uC for 10 sec., 50uCf o r5s e c . ,6 0 uCf o r4m i n .U p o n
completion of sequencing, 20 ml of 62.5% EtOH/1M KOAc,
pH 4.5 was added to each reaction and the sequence plates were
centrifuged at 4000 rpm at 4uC for 45 min. The samples were
resuspended in 15 ul of formamide and electrophoresed on an ABI
3700 capillary instrument. Sequence trace files were evaluated using
the Phred, Phrap and Consed programs, and potential variants were
identified by using the PolyPhred program [66,67]. Single nucleotide
polymorphisms (SNPs) were verified by manual evaluation of the
individual forward and reverse sequence traces. In addition, all
sequence assemblies were manually scanned for insertions, deletions
and polymorphic positions undetected by PolyPhred. Tag SNPs were
selected using the ldSelect algorithm [68] with an r
2 cutoff value of
0.64 on all SNPs with a minor allele frequency .5%.
Genotyping was carried out using one of two different methods:
an oligonucleotide ligation, PCR assay for simultaneous genotyp-
ing of 48 single nucleotide polymorphisms (SNPs) in a multiplexed,
384-well plate method, SNPlex (Applied Biosystems), and a single-
step homogeneous SNP genotyping using a 59-nuclease assay,
TaqMan (Applied Biosystems). The SNPlex assay, pooling 48
different SNPs into a single genotyping assay, was applied to DNA
samples processed in 384-well plate format through an automated
protocol which included: SNP-specific oligonucleotide ligation,
PCR amplification, immobilization, hybridization, elution, and
separation and fluorescent detection on an ABI 3730xl capillary
instrument. For all SNPs genotyped by SNPlex, the call rate on the
932 individuals in the UT and WI cohort was 99.26% after 35
individuals were excluded for low genotyping rates (.10% missing
genotypes). TaqMan genotyping was processed in 384-well plate
format on the five SNPs in the combined UT-WI-LHS cohorts,
and the call rate on 2,006 individuals was 99.42% after 29
individuals were excluded for missing genotypes. For the five SNPs
genotyped by TaqMan and SNPlex methods in 236 individuals,
there were three discordant calls, all in a single individual. For the
87 SNPs genotyped by SNPlex and resequencing in the subset of
192 individuals, the concordance rate was 99.7%.
Statistical Analysis
SNP genotypes were evaluated for standard summary measures
including genotyping rates, allele and genotype frequencies, and
Hardy-Weinberg equilibrium tests. Standard case/control allelic
x
2 analyses were used to test the association of SNPs with
dichotomized FTND, as well as the Cochran-Armitage trend test
using the computer program, PLINK [69]. Empirical significance
levels of allelic tests were evaluated by phenotype-genotype
permutation testing using the PLINK adaptive mode. The logistic
regression analyses reported in Tables 3–4 and Figure 2 were
computed using SYSTAT 10.2 (Richmond, CA: SYSTAT
Software Inc.). Dummy coding was used for haplotype and sex,
while ordinal coding was used for age of onset of daily smoking.
Haplotype estimation and individual assignment were carried out
on genotypic data using fastPHASE [70], and independently
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(http://www-gene.cimr.cam.ac.uk/clayton/software). Haplotype-
based association analyses for omnibus and haplotype-specific tests
were carried out using PLINK. To evaluate potential population
stratification effects, the UT and WI cohorts were analyzed for
population admixture using STRUCTURE [71] on 94 non-
related loci and an assumed population of 2. No significant
admixture was observed, supporting the European American self
report. Also, cohorts did not differ in CHRNA5-A3-B4 haplotype
frequency (x2 (6, N=5654)=8.2, P=0.22, see Table 2), suggesting
they were drawn from the same population.
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